Pacific Biosciences Of California | PACB - Pre Tax Profit

Stock Price
1.55
Daily Change
-0.05 -2.83%
Monthly
22.62%
Yearly
39.19%
Q2 Forecast
1.53

Pacific Biosciences Of California reported $-40.17M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Agilent USD 442M 1000K Sep/2025
Bruker USD -72.6M 73.1M Sep/2025
Danaher USD 1.24B 138M Mar/2026
General Electric Aerospace USD 2.2B 654M Mar/2026
Illumina USD 220M 86M Sep/2025
Myriad Genetics USD 4.6M 3.4M Dec/2025
Pacific Biosciences Of California USD -40.17M 2.55M Dec/2025
Quidel USD -756.9M 527.3M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Standard Biotools USD -22.03M 10.87M Dec/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Waters USD 170.12M 7.57M Sep/2025